Purchase Order N3239823P0704
- Not listed
- The Naval Medical Research Command has awarded a firm fixed-price purchase order valued at $49,409.64 to Becton, Dickinson and Company (BD), through its BD Biosciences division, for preventive maintenance and repair services on a BD LSRFortessa flow cytometer located at the command's facility in Silver Spring, Maryland. The contract was awarded on September 27, 2025, with an ultimate completion date of September 26, 2026, with no small business set-aside designation. BD Biosciences is the...
- Becton, Dickinson and Company, through its BD Biosciences division, was awarded a firm fixed-price purchase order valued at $111,491.64 for service and support on an LSRFortessa flow cytometry system (Serial #R647800L6075) without lasers. The contract was awarded on March 17, 2026, by the Office of Logistics and Acquisition Operations, a civilian federal agency, with performance continuing through March 16, 2029. The place of performance is Bethesda, Maryland 20892. This contract involves...
- Becton, Dickinson and Company, through its BD Biosciences division, was awarded a firm fixed-price purchase order valued at $88,457.40 by the Bureau of Medicine and Surgery (a Defense agency component) on November 1, 2025, for maintenance services on FACSymphony A1 flow cytometry instruments and FACS Flow Supply System equipment. The contract specifies two instrument configurations identified by catalog model numbers and serial numbers, with an ultimate completion date of October 31, 2030,...
- The U.S. Department of the Navy's Bureau of Medicine and Surgery (BUMED) awarded a $47,886.84 firm fixed-price purchase order contract to Becton, Dickinson and Company (BD) to provide maintenance services for a BD LSRFortessa flow cytometry instrument and associated equipment. The contract has a period of performance from September 27, 2024 to September 26, 2025, with two scheduled preventive maintenance visits per year. This sole-source award is not set aside and is being procured under FAR...
- Becton, Dickinson and Company (BD), through its BDB Division operating as BD Biosciences, was awarded a $20,297.72 firm fixed-price delivery order by the Bureau of Medicine and Surgery (an element of the Department of Defense) on February 11, 2020, with an ultimate completion date of February 18, 2021. The contract covers service maintenance on a BD FACSCanto II flow cytometer (serial number V96101183), a sophisticated instrument used for cell analysis and research applications. The work will be...
- Becton, Dickinson and Company (BD), through its BDB Division operating as BD Biosciences, received a $5,000 firm fixed price purchase order from the Bureau of Medicine and Surgery (Naval Medical) for repair services, with an ultimate completion date of May 29, 2015. This non-set-aside contract was awarded on April 29, 2015 and will be performed in San Jose, California. BD Biosciences specializes in providing sophisticated flow cytometry instruments, cell imaging technologies, reagents, and...
- Becton, Dickinson and Company (BD), through its BD Biosciences division, was awarded a purchase order by a civilian federal agency's Office of Acquisitions and Grants for preventive maintenance and repair services on a Becton Dickinson Immunocytometry System Flow Cytometer (serial number E97500138) located in Lafayette, Louisiana. The contract, valued at $5,246.25 under a firm fixed-price arrangement, was awarded on August 25, 2023, with an ultimate completion date of August 29, 2024. The...
- Becton, Dickinson and Company (BD), operating through its BDB Division as BD Biosciences, was awarded a delivery order contract on October 1, 2006, for maintenance services on a FACSORT 5-day flow cytometry system. The contract, valued at $13,425 and set to conclude on September 30, 2007, is a child delivery order under a larger indefinite delivery vehicle and represents continuation of technical support for sophisticated laboratory instrumentation. The work will be performed at the Bethesda,...
- On January 13, 2025, the National Heart Lung and Blood Institute (NHLBI) awarded a firm fixed-price purchase order valued at $51,828.84 to Becton, Dickinson and Company's BD Biosciences division for maintenance services on a Fortessa flow cytometer analyzer. The contract, designated as part of the FY26 UDO Initiative, has an ultimate completion date of January 12, 2026, and will be performed in San Jose, California. This award requires no small business set-aside and represents a child...
- The Department of the Navy Bureau of Medicine and Surgery awarded a $15,000 firm fixed price purchase order to Becton, Dickinson and Company BD Biosciences, Systems and Reagents Division for preventive maintenance services on a flow cytometer. As the prime contractor, BD Biosciences will perform the requested yield services to maintain functionality of the medical device equipment. The Bureau of Medicine and Surgery supports Navy and Marine Corps medical readiness through programs such as...
The U.S. Navy Bureau of Medicine and Surgery awarded a $107,915 firm fixed price purchase order to Becton, Dickinson and Company (BD), through its BD Biosciences division, for maintenance services on a BD LSR Fortessa flow cytometer located in San Antonio, Texas. This award represents the second renewal year of the maintenance contract for the specific instrument (Serial Number H64955800120, ECN 98471), with an ultimate completion date of September 22, 2028. The contract was awarded without a small business set-aside designation on September 23, 2023. BD Biosciences is a leading global medical technology manufacturer specializing in sophisticated flow cytometry systems, cell imaging equipment, and associated reagents and services for federal healthcare and research institutions. The company maintains an established track record of providing maintenance and technical support for advanced laboratory instrumentation across multiple Department of Defense and other federal agencies. Flow cytometry systems like the LSR Fortessa are critical analytical tools used in biomedical research and clinical diagnostics, and BD's comprehensive maintenance capabilities ensure continuous operational reliability of this essential equipment for Navy medical and research operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Exercise an Option | $0 | 7/21/25 | |
| P00001 | Exercise an Option | $21.6k | 9/23/24 | |
| Not listed | Not listed | $21.6k | 8/8/23 |